Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure

Circulation

Volumn 96, Issue 4, 1997, Pages 1165-1172

  Steimle, Anthony E ^a,b   Stevenson, Lynne Warner ^a,b   Chelimsky Fallick, Catherine ^a   Fonarow, Gregg C ^a   Hamilton, Michele A ^a   Moriguchi, Jaime D ^a   Kartashov, Alex ^a,c   Tillisch, Jan H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Diuretics; Heart failure; Hemodynamics; Vasodilation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0030744896     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1165     Document Type: Article

References (46)

1. Stevenson LW, Tillisch JH. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation. 1986;74:1303-1308.
2. Kukin ML. Vasodilator therapy and survival in chronic congestive heart failure. J Am Coll Cardiol. 1992;19:1360-1362.
3. Weiland DS, Konstam MA, Martin TT, Cohen SR, Zile MR, Das D. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1986;58:1046-1050.
4. Stevenson LW, Belil D, Grover McKay M, Brunken RC, Schwaiger M, Tillisch JH, Schelbert HR. Effects of afterload reduction on left ventricular volume and mitral regurgitation in severe congestive heart failure. Am J Cardiol. 1987;60:654-658.
5. Stevenson LW, Brunken RC, Belil D, Grover-McKay M, Schwaiger M, Schelbert HR, Tillisch JH. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol. 1990;15:174-180.
6. Guiha NH, Cohn JN, Mikulic E, Franciosa JA, Liman CJ. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med. 1974;291:587-592.
7. Asanoi H, Kameyama T, Ishizaka S, Nozawa T, Inoue H. Energetically optimal left ventricular pressure for the failing human heart. Circulation. 1996;93:67-73.
8. Laskey WK, Reichek N, Sutton MS, Unterecker WJ, Hirshfeld JW. Matching of myocardial oxygen consumption to mechanical load in human left ventricular hypertrophy and dysfunction. J Am Coll Cardiol. 1984;3:291-300.
9. Katz AM. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322: 100-110.
10. Watanabe J, Levine MJ, Bellotto F, Johnson RG, Grossman W. Effects of coronary venous pressure on left ventricular diastolic distensibility. Circ Res. 1990;67:923-932.
11. Kubo SH, Ormaza SM, Francis GS, Holmer SC, Olivari MT, Bolman RM, Shumway SJ. Trends in patient selection for heart transplantation. J Am Coll Cardiol. 1993;21:975-981.
12. Stevenson LW, Steimle AE, Fonarow G, Kermani M, Kermani D, Hamilton MA, Moriguchi JD, Walden J, Tillisch JH, Drinkwater DC, Laks H. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 1995;25:163-170.
13. Stevenson LW, Sietsema K, Tillisch JH, Lem V, Walden J, Kobashigawa JA, Moriguchi J. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation. 1990;81:78-85.
14. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, Tillisch JH, Creaser JA, Albanese E. Effect of direct vasodilation vs angiotensin-converting-enzyme inhibition on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol. 1992;19:842-850.
15. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R, for the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiac en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493-498.
16. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 1995;333:77-82.
17. Russell RO, Rackley CE, Pombo J, Hunt D, Potanin C, Dodge HT. Effects of increasing left ventricular filling pressure in patients with acute myocardial infarction. J Clin Invest. 1970;49:1539-1546.
18. Chatterjee K, Parmley WW, Swan HJC, Berman G, Forrester J, Marcus HS. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation. 1973;48:684-690.
19. Hamilton MA, Stevenson LW, Child JS, Moriguchi JD, Walden J, Woo M. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol. 1991;67:259-263.
20. Gilbert EM, Sandoval A, Larrabee P, Renlund DG, O'Connell JB, Bristow ME. Lisinopril lowers cardiac adrenergic drive and increases β-receptor density in the failing human heart. Circulation. 1993;88:472-480.
21. Osteriziel KJ, Rohrig N, Dietz R, Manthey J, Hecht J, Kubler W. Influence of captopril on the arterial baroeceptor reflex in patients with heart failure. Eur Heart J. 1988;9:1137-1145.
22. Masiel AS, Michel MC, Ziegler MG, Carter SM. Regulation of cardiac β-adrenergic receptors by captopril: implications for congestive heart failure. Circulation. 1989;80:669-675.
23. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril on the infarcted left ventricle of the rat. Circ Res. 1985;57: 1355-1364.
24. Weber KT, Brilla CG. Pathologic hypertrophy and the cardiac interstitium: fibrosis and the renin-angiotensin-aldosterone system. Circulation. 1990;83:1840-1865.
25. Juggi JS, Koenig-Berard E, Vitou P. Vasodilator therapy: interaction of nitrates with angiotensin-converting enzyme inhibitors. Can J Cardiol. 1991;7:419-425.
26. Massie BM, Singh SN, Fletcher RD, Fisher SG. Effect of amiodarone on ejection fraction and CHF status in the VA cooperative study of amiodarone for CHF. Circulation. 1995;92(suppl I):I-143. Abstract.
27. Nul DR, Doval HR, Grancelli HO, Varini SD, Soifer S, Scapin, O, Prieto N. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. Circulation. 1995;92(suppl I):I-666. Abstract.
28. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation. 1992;86:431-438.
29. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty JD, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrated in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
30. Cody RJ, Torre S, Clark M, Pondolfino K. Age-related hemodynamic, renal, and hormonal differences among patients with CHF. Arch Intern Med. 1989;149:1023-1028.
31. Kramer BL, Massie BM, Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983;67:807-816.
32. Ziesche S, Cobb FR, Cohn JN, Johnson G, Tristani F. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure: results from V-HeFT 1 and V-HeFT II. Circulation 1993;87(suppl VI):VI-56-VI-64.
33. Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehman M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. Circulation. 1989;79:491-502.
34. Franciosa JA, Dunkman B, Leddy CL. Hemodynamic effects of vasodilators and long-term response in heart failure. J Am Coll Cardiol. 1984;3:1521-1530.
35. Poole-Wilson PA, Buller NP, Lindsay DC. Blood flow and skeletal muscle in patients with heart failure. Chest. 1992;101(suppl): 330S-332S.
36. Wilson JR, Mancini DM. Factors contributing to exercise limitation of heart failure. J Am Coll Cardiol. 1993;22(suppl A):93A-8A.
37. Sullivan MJ, Cobb FR. Central hemodynamic response to exercise in patients with chronic heart failure. Chest. 1992;101(suppl): 340S-346S.
38. Massie B, Ports T, Chatterjee K, Parmley W, Ostland J, O'Young J, Haugham F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981;63:269-278.
39. Anguita M, Arizon JM, Bueno G, Latre JM, Sancho M, Torres F, Gimenez D, Concha M, Valles F. Clinical and hemodynamic predictors of survival in patients aged <65 with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1993;72:413-417.
40. Fonarow GC, Stevenson LW, Steimle AE, Hamilton MA Moriguchi JD, Walden JA, Tillisch JH. Persistently high left ventricular filling pressures predict mortality despite angiotensin converting enzyme inhibition in advanced heart failure. Circulation. 1994;90(pt 2):I-488.
41. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak oxygen consumption for optimal of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
42. Gottlieb SS, Kukin ML, Penn J, Fisher ML, Cines M, Medina N, Yushak M, Taylor M Packer M. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 1993;22:963-967.
43. Leier CV, Huss P, Magorien RD, Unverferth DV. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983;67:817-822.
44. Mehra A, Enrique O, Avraham S, Johnson JV, Elkayam U. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril. Am J Cardiol. 1992;70:1310-1314.
45. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.
46. Pierpont GL, Francis GS. Medical management of terminal cardiomyopathy. J Heart Transplant. 1982;2:18-27.